antipyrine has been researched along with warfarin in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (51.67) | 18.7374 |
1990's | 6 (10.00) | 18.2507 |
2000's | 12 (20.00) | 29.6817 |
2010's | 11 (18.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Caron, G; Ermondi, G | 1 |
Jolivette, LJ; Ward, KW | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Passananti, GT; Vesell, ES | 1 |
Atwood, JL; Breckenridge, AM; Mossman, S; Serlin, MJ; Sibeon, RG; Williams, JR; Willoughby, JM | 1 |
Ladefoged, O | 1 |
Breckenridge, A | 2 |
Conney, AH; Kapitulnik, J; Popper, PJ | 1 |
Buening, MK; Conney, AH; Fortner, JG; Kapitulnik, J; Poppers, PJ | 1 |
Aitio, ML; Arvela, P; Bartsch, H; Béréziat, JC; Hietanen, E | 1 |
Humphries, TJ | 1 |
Lønning, PE | 1 |
Rieth, H; Sauerbrey, N | 1 |
Kvinssland, S; Lønning, PE; Ueland, PM | 1 |
Bakke, O; Kvinnsland, S; Lundgren, S; Ueland, PM; Utaaker, E | 1 |
Bachmann, KA; Jahn, D; Schwartz, J; Yang, C | 2 |
Alván, G | 1 |
Conney, AH; Kappas, A | 1 |
Hanano, M; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
Hucker, HB; Stauffer, SC; White, SE | 1 |
Coldwell, BB; Grice, HC; Zawidzka, ZZ | 1 |
Rawlins, MD; Smith, SE | 1 |
Vesell, ES | 1 |
Breckenridge, A; Moss, DW; Neale, G; Orme, M; Whitfield, JB | 1 |
Andreasen, PB; Vesell, ES | 1 |
Breckenridge, A; Davies, DS; Davies, L; Orme, M | 1 |
Altland, K; Goedee, HW | 1 |
Breckenridge, A; Orme, M | 2 |
Breckenridge, A; Davies, DS; Orme, ML; Thorgeirsson, S | 1 |
Breckenridge, A; Brooks, RV; Davies, DS; Orme, ML; Thorgeirsson, S | 1 |
Luczynska, C; Wilson, K | 1 |
Goldberg, DM | 1 |
Passananti, GT; Piroli, RJ; Shively, CA; Vesell, ES | 1 |
Arvela, P; Klebovich, I; Pelkonen, O; Rautio, A; Salonpää, P; Sotaniemi, EA | 1 |
Bliesath, H; Hartmann, M; Huber, R; Radtke, HW; Steinijans, VW; Wurst, W; Zech, K | 1 |
Buss, DC; Cassidy, SL; Hale, A; Routledge, PA | 1 |
Shinohara, Y | 1 |
Dolcet, X; Encinas, M; Eritja, N; Llobet, D; Llombart-Cussac, A; Marti, RM; Matias-Guiu, X; Schoenenberger, JA; Sorolla, A; Yeramian, A | 1 |
Jiang, H; Lei, D; Liang, C; Xue, Y; Yao, Q; Zhou, Z | 1 |
Chen, NH; Han, N; Zhang, W; Zuo, W | 1 |
Hirano, T; Inatomi, Y; Suzuki, Y; Yonehara, T | 1 |
Ikarashi, N; Kajiwara, S; Kawabata, A; Kitaoka, S; Kon, R; Nagoya, C; Ochiai, W; Saito, M; Sugiyama, K | 1 |
10 review(s) available for antipyrine and warfarin
Article | Year |
---|---|
Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
Topics: Aminopyrine; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Humans; Omeprazole; Phenytoin; Propranolol; Theophylline; Warfarin | 1991 |
Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
Topics: Antipyrine; Binding Sites; Humans; Metabolic Clearance Rate; Metabolism, Inborn Errors; Orosomucoid; Pharmaceutical Preparations; Phenotype; Polymorphism, Genetic; Propranolol; Protein Binding; Serum Albumin; Warfarin | 1986 |
Interindividual differences in the metabolism of xenobiotics.
Topics: Aflatoxin B1; Aflatoxins; Antipyrine; Benzopyrenes; Biotransformation; Carcinogens; Coumarins; Desipramine; Diet; Dihydroxydihydrobenzopyrenes; Hexobarbital; Humans; Liver; Microsomes, Liver; Pharmaceutical Preparations; Smoking; Steroids; Zoxazolamine | 1985 |
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Topics: Animals; Antipyrine; Barbiturates; Biological Availability; Chlorpromazine; Diazepam; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Pentazocine; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Propranolol; Quinidine; Rats; Species Specificity; Tissue Distribution; Tolbutamide; Valproic Acid; Warfarin | 1985 |
Recent progress in pharmacogenetics.
Topics: Adult; Aged; Alcohol Oxidoreductases; Antipyrine; Asian People; Child, Preschool; Cholinesterases; Cyanides; Dicumarol; Diseases in Twins; Drug Hypersensitivity; Erythrocytes; Favism; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Isoniazid; Liver; Male; Metabolism, Inborn Errors; Middle Aged; Pharmacogenetics; Phenylbutazone; Phenylthiourea; Phenytoin; Pregnancy; Primaquine; Twins; Warfarin | 1969 |
[Genetically dependent variability of drug effects].
Topics: Anemia, Hemolytic; Anesthesia, General; Anesthetics; Animals; Antipyrine; Apnea; Atropine; Body Temperature; Coumarins; Cyanosis; Deficiency Diseases; Dexamethasone; Dogs; Drug Tolerance; Enzymes; Female; Glucosephosphate Dehydrogenase; Humans; Intraocular Pressure; Isonicotinic Acids; Male; Meperidine; Mice; Oxyphenbutazone; Pharmacogenetics; Phenacetin; Phenylbutazone; Phenytoin; Proteins; Rabbits; Rats; Succinylcholine | 1970 |
The clinical significance of the effects of cigarette smoking on drug disposition.
Topics: Acetaminophen; Antipyrine; Benzodiazepines; Chlorpromazine; Clomipramine; Codeine; Humans; Pharmaceutical Preparations; Phenacetin; Propranolol; Smoking; Theophylline; Warfarin | 1983 |
The expanding role of microsomal enzyme induction, and its implications for clinical chemistry.
Topics: Acetaminophen; Alcoholism; Animals; Antipyrine; Aryl Hydrocarbon Hydroxylases; Electron Transport; Energy Intake; Enzyme Induction; Epilepsy; Female; Humans; Male; Microsomes, Liver; Pharmacology; Phenobarbital; Phenylbutazone; Phenytoin; Smoking; Tolbutamide; Warfarin | 1980 |
Lack of pantoprazole drug interactions in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin | 1994 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
6 trial(s) available for antipyrine and warfarin
Article | Year |
---|---|
Cimetidine: interaction with oral anticoagulants in man.
Topics: Acenocoumarol; Administration, Oral; Adult; Aged; Antipyrine; Biological Availability; Cimetidine; Clinical Trials as Topic; Drug Synergism; Female; Guanidines; Half-Life; Humans; Male; Middle Aged; Phenindione; Prothrombin Time; Warfarin | 1979 |
Oral anticoagulants--the totem and the taboo.
Topics: Animals; Anticoagulants; Antipyrine; Barbiturates; Blood Coagulation; Chloral Hydrate; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Induction; Hemorrhage; Humans; Hypnotics and Sedatives; Liver; Myocardial Infarction; Rats; Research Design; Vitamin K; Warfarin | 1976 |
[Interaction studies with fluconazole, a new triazole antifungal drug].
Topics: Adult; Antipyrine; Cimetidine; Clinical Trials as Topic; Contraceptives, Oral; Cyclosporins; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Male; Testosterone; Tolbutamide; Warfarin | 1989 |
Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
Topics: Administration, Oral; Adult; Antipyrine; Clinical Trials as Topic; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Liver Cirrhosis; Male; Middle Aged; Solutions; Spectrophotometry, Ultraviolet; Time Factors; Tolbutamide; Warfarin | 1974 |
Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test.
Topics: Acetylation; Adult; Analysis of Variance; Antipyrine; Caffeine; Coumarins; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hypoglycemic Agents; Male; Middle Aged; Uracil; Xanthines | 1995 |
Lack of pantoprazole drug interactions in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin | 1994 |
45 other study(ies) available for antipyrine and warfarin
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Anomalous results of studies on drug interaction in man. II. Halofenate (mk-185) and antipyrine, bishydroxycoumarin, and warfarin.
Topics: Adult; Aldehyde-Lyases; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Depression, Chemical; Dicumarol; Dogs; Drug Interactions; Ethylmorphine-N-Demethylase; Glycolates; Half-Life; Halofenate; Humans; Male; Mice; Microsomes, Liver; Rats; Stimulation, Chemical; Time Factors; Warfarin | 1975 |
The effect of carbon tetrachloride (CCl4) induced liver damage on the volume of distribution, the elimination half-life and body clearance of antipyrine and warfarin in rabbits.
Topics: Animals; Antipyrine; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Half-Life; Liver; Male; Rabbits; Warfarin | 1979 |
Comparative metabolism of benzo[a]pyrene and drugs in human liver.
Topics: Adolescent; Adult; Aged; Antipyrine; Benzopyrene Hydroxylase; Benzopyrenes; Coumarins; Female; Hexobarbital; Humans; In Vitro Techniques; Liver; Male; Middle Aged; Mixed Function Oxygenases; Oxidoreductases; Pharmaceutical Preparations; Zoxazolamine | 1977 |
Activation of monooxygenases in human liver by 7,8-benzoflavone.
Topics: Adolescent; Adult; Antipyrine; Autopsy; Benzopyrenes; Biopsy; Coumarins; Dealkylation; Enzyme Activation; Female; Flavonoids; Hexobarbital; Humans; Hydroxylation; In Vitro Techniques; Liver; Male; Microsomes, Liver; Middle Aged; Oxygenases; Zoxazolamine | 1977 |
Drug metabolism in rats with cancer induced by N-nitrosodiethylamine and phenobarbital.
Topics: Animals; Antipyrine; Debrisoquin; Diethylnitrosamine; Liver; Male; Microsomes, Liver; Neoplasms, Experimental; Organ Size; Phenobarbital; Rats; Rats, Wistar; Stereoisomerism; Warfarin | 1992 |
Aminoglutethimide enzyme induction: pharmacological and endocrinological implications.
Topics: Aminoglutethimide; Antipyrine; Aromatase Inhibitors; Breast Neoplasms; Digitoxin; Drug Interactions; Estrogens; Humans; Theophylline; Warfarin | 1990 |
Aminoglutethimide as an inducer of microsomal enzymes. Part 1: Pharmacological aspects.
Topics: Aminoglutethimide; Antipyrine; Dexamethasone; Digitoxin; Drug Interactions; Enzyme Activation; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Microsomes; Theophylline; Warfarin | 1986 |
Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antipyrine; Breast Neoplasms; Digitoxin; Female; Humans; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Progesterone Congeners; Warfarin | 1986 |
The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
Topics: Animals; Antipyrine; Liver; Male; Metabolic Clearance Rate; Mixed Function Oxygenases; Models, Biological; Pharmaceutical Preparations; Phenytoin; Rats; Rats, Inbred Strains; Theophylline; Valproic Acid; Warfarin | 1988 |
The use of single sample clearance estimates to probe hepatic drug metabolism in rats. II.
Topics: Animals; Antipyrine; Benzoflavones; beta-Naphthoflavone; Clofibrate; Drug Interactions; Liver; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Phenobarbital; Rats; Rats, Inbred Strains; Safrole; Theophylline; Valproic Acid; Warfarin | 1988 |
Chloral hydrate and oral anticoagulants.
Topics: Anticoagulants; Antipyrine; Binding Sites; Blood Proteins; Chloral Hydrate; Dicumarol; Drug Interactions; Humans; Warfarin | 1972 |
Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.
Topics: Acetamides; Animals; Anticholesteremic Agents; Antipyrine; Aspirin; Blood Proteins; Carbon Isotopes; Chlorothiazide; Clofibrate; Dicumarol; Digitoxin; Drug Interactions; Fluorine; Glycolates; Half-Life; Haplorhini; Humans; Hypolipidemic Agents; Indomethacin; Macaca; Phenothiazines; Phenylbutazone; Salicylates; Warfarin | 1972 |
Effect of non-narcotic analgesics on anticoagulant-induced hypoprothrombinemia in rats.
Topics: Acetaminophen; Acetanilides; Administration, Oral; Animals; Antipyrine; Aspirin; Blood Coagulation; Dicumarol; Female; Hypoprothrombinemias; Injections, Intraperitoneal; Male; Phenacetin; Phenindione; Phenylbutazone; Rats; Salicylamides; Sodium Salicylate; Species Specificity; Time Factors; Warfarin | 1972 |
Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.
Topics: Adipates; Adult; Antipyrine; Biopharmaceutics; gamma-Glutamyltransferase; Half-Life; Humans; Hydroxycorticosteroids; Oxidation-Reduction; Pharmaceutical Preparations; Phenylbutazone; Smoking; Sugar Acids; Warfarin | 1974 |
Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man.
Topics: Acyltransferases; Adult; Aged; Amobarbital; Antipyrine; Chlordiazepoxide; Diazepam; Enzyme Induction; Female; gamma-Glutamyltransferase; Humans; Male; Methaqualone; Middle Aged; Nitrazepam; Secobarbital; Time Factors; Warfarin | 1973 |
Dose-dependent enzyme induction.
Topics: Amobarbital; Animals; Antipyrine; Dose-Response Relationship, Drug; Enzyme Induction; Half-Life; Humans; Microsomes, Liver; Morphinans; Oxidoreductases, N-Demethylating; Phenobarbital; Rats; Secobarbital; Sleep; Warfarin | 1973 |
Clinical implications of enzyme induction.
Topics: Alcohols; Amobarbital; Animals; Antipyrine; Benzazepines; Blood Coagulation; Chloral Hydrate; Chlordiazepoxide; Enzyme Induction; Ethanol; Fluorometry; Half-Life; Humans; Hydrocortisone; Hypnotics and Sedatives; Ketones; Kinetics; Male; Metabolism; Microsomes, Liver; Morphinans; Nitro Compounds; Paralysis; Phenobarbital; Rats; Rheumatic Heart Disease; Secobarbital; Sleep; Time Factors; Warfarin | 1971 |
Pathophysiological factors influencing drug kinetics.
Topics: Absorption; Age Factors; Antipyrine; Chloral Hydrate; Environmental Exposure; Ethanol; Female; Humans; Kinetics; Liver Diseases; Male; Pharmaceutical Preparations; Pharmacogenetics; Phenylbutazone; Pregnancy; Sex Factors; Smoking; Time Factors; Warfarin | 1971 |
Induction of drug metabolizing enzymes in man and rat by dichloralphenazone.
Topics: Animals; Antipyrine; Chloral Hydrate; Enzyme Induction; Humans; In Vitro Techniques; Microsomes, Liver; Pentobarbital; Rats; Warfarin | 1969 |
Induction of drug metabolizing enzymes in man.
Topics: Antipyrine; Carbon Isotopes; Chloral Hydrate; Enzyme Induction; Humans; Microsomes; Warfarin | 1970 |
Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).
Topics: Animals; Antipyrine; Carbon Isotopes; Chloral Hydrate; Enzyme Induction; Glucocorticoids; Humans; Liver; Microsomes, Liver; Morphine; Pentobarbital; Rats; Warfarin; Zoxazolamine | 1971 |
Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia.
Topics: Adult; Antipyrine; Female; Humans; Kinetics; Protein Binding; Serum Albumin; Thrombophlebitis; Warfarin | 1981 |
In vitro drug adsorption to charcoal, silicas, acrylate copolymer and silicone oil with charcoal and with acrylate copolymer.
Topics: Acetaminophen; Acrylates; Adsorption; Antipyrine; Binding Sites; Charcoal; Metoclopramide; Pharmaceutical Preparations; Silicon Dioxide; Silicone Oils; Warfarin | 1997 |
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.
Topics: Antioxidants; Antipyrine; Apoptosis; Ascorbic Acid; Blotting, Western; Boronic Acids; Bortezomib; Butylated Hydroxyanisole; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Coumarins; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Edaravone; Endometrial Neoplasms; Ergothioneine; Female; Humans; Leupeptins; Oligopeptides; Proteasome Inhibitors; Pyrazines; Ubiquitin; Vitamin E; Vitamins | 2008 |
Ultrasound-promoted greener synthesis of novel trifurcate 3-substituted-chroman-2,4-dione derivatives and their drug-likeness evaluation.
Topics: Aldehydes; Antineoplastic Agents; Antipyrine; Chromans; Chromones; Coumarins; Edaravone; Molecular Structure; Pyrazolones; Sound; Water | 2012 |
Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.
Topics: Animals; Antipyrine; bcl-2-Associated X Protein; Brain Ischemia; CA1 Region, Hippocampal; Caspase 3; Cell Death; Coumarins; Disease Models, Animal; Disks Large Homolog 4 Protein; Drug Evaluation, Preclinical; Edaravone; Free Radical Scavengers; Intracellular Signaling Peptides and Proteins; Learning Disabilities; Male; Maze Learning; Membrane Proteins; Neurons; Neuroprotective Agents; Nootropic Agents; Random Allocation; Rats, Sprague-Dawley; Spatial Memory; Synapsins | 2015 |
[Dystypia after ischemic stroke: a disturbance of linguistic processing for Romaji (Romanized Japanese)?].
Topics: Aged; Agraphia; Anticoagulants; Antipyrine; Aphasia; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Edaravone; Female; Free Radical Scavengers; Heparin; Humans; Japan; Language; Stroke; Stroke Rehabilitation; Warfarin; Word Processing | 2015 |
Changes in the Expression of Aquaporin-3 in the Gastrointestinal Tract Affect Drug Absorption.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antipyrine; Aquaporin 3; Caco-2 Cells; Cell Membrane Permeability; Gastrointestinal Tract; Humans; Intestinal Absorption; Membrane Fluidity; Permeability; Warfarin | 2019 |